Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00026247 · ClinicalTrials.gov registry record · NA
Radiofrequency Ablation in Treating Patients With Bone Metastases
A NA study, sponsored by American College of Radiology Imaging Network.
- Completed
- Registry status
- NA
- Development phase
- 66
- Enrollment target
NCT00026247 is a NA study that has completed, run by American College of Radiology Imaging Network. The registered enrollment target is 66 participants.
The verdict
NCT00026247, a NA study, has completed, sponsored by American College of Radiology Imaging Network.
- COMPLETED
- Registry status
- NA
- Development phase
- 66 participants
- Enrollment target
Study Summary
RATIONALE: Radiofrequency ablation may be effective in decreasing pain from bone metastases. PURPOSE: Phase I/II trial to study the effectiveness of radiofrequency ablation in decreasing pain in patients who have bone metastases.
Interventions
- PROCEDURE pain therapy
- PROCEDURE radiofrequency ablation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2001-11 |
| Est. Completion | 2010-02-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00026247
The ClinicalTrials.gov registry entry for NCT00026247 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 66 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is American College of Radiology Imaging Network, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which pain therapy is the first listed.
NCT00026247 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00026247 about?
NCT00026247 is a clinical study titled "Radiofrequency Ablation in Treating Patients With Bone Metastases". RATIONALE: Radiofrequency ablation may be effective in decreasing pain from bone metastases. PURPOSE: Phase I/II trial to study the effectiveness of radiofrequency ablation in decreasing pain in patients who have bone metastases.
What is the current status of trial NCT00026247?
This trial is currently completed. It is a NA study. The enrollment target is 66 participants. The study started on 2001-11. Estimated completion is 2010-02-15.
What interventions are being tested in trial NCT00026247?
The interventions under investigation include: pain therapy (PROCEDURE), radiofrequency ablation (PROCEDURE).
Who is sponsoring clinical trial NCT00026247?
This trial is sponsored by American College of Radiology Imaging Network, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.